Skip to main content


March 8, 2021

We are excited, ready, and committed to elevate diversity, equity and inclusion in the School of Medicine.

A joyous time in Hillsborough as Wohl leads the way for COVID-19 vaccinations

December 21, 2020

Healthcare workers and other frontline staff at UNC Hospitals Hillsborough Campus began receiving COVID-19 vaccines Dec. 15, marking a significant turning point in the response to the pandemic. David Wohl, MD, Medical Director of the COVID Vaccination Clinic at Hillsborough, was the first to be vaccinated.

Tar Heel of the Month: David Wohl, MD

December 20, 2020

David Wohl, MD, is the News & Observer’s November Tar Heel of the Month, which honors people who have made significant contributions to North Carolina and the region.

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells

September 11, 2020

The UNC School of Medicine lab of Camille Ehre, PhD, generated high-powered microscopic images showing startlingly high SARS-CoV-2 viral loads on human respiratory surfaces, ready to spread infection in infected individuals and transmit infection to others.

UNC Ramps Up Convalescent Plasma Clinical Trial to Fight COVID-19

September 10, 2020

On the heels of FDA authorization of convalescent plasma as a treatment for COVID-19, researchers at UNC are conducting a clinical trial to determine the safety and efficacy of plasma that includes a higher amount of neutralizing antibodies against SARS-CoV-2.

UNC Researchers Enroll COVID-19 Vaccine Phase 3 Trial Participants

September 9, 2020

Led by Cindy Gay, MD, clinical researchers in the UNC Division of Infectious Diseases are leaning on years of experience and expertise to partake in a large phase 3 clinical trial for a COVID-19 vaccine. Ronald Falk, MD, Chair of the UNC Department of Medicine, is one of the trial’s first participants.